Skip to content
★ Sign in to follow
에스

에스티큐브 Stock: price and insider trades · South Korea

KR·Mcap ₩447BHealth Care

No insider purchase over the last 90 days. The latest, by 바이오메디칼홀딩스, was filed 03 Dec 2024.

에스티큐브: what insiders have been doing

This page follows insider dealings at 에스티큐브 as filed with DART (FSS), a company from the Health Care sector. In the past year (30 October 2025 to 30 October 2026), 1 filing came from 1 insider.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

There has been no open-market purchase by an insider of 에스티큐브 for at least a year.

For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 1 filing here. Over the whole record (from 2021), the tally stands at 7 purchases and 15 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.

Insider Decl.
50
Thresholds
n/a
Buy Volume
n/a
7 ops. · all time
Sell Volume
n/a
15 ops. · all time

Who traded when

BuySale
Yoo Stephen1 buy
바이오메디칼홀딩스1 buy
박준용1 buy
에스티사이언스1 buy
에스티큐브앤컴퍼니1 buy

Financial data

as of FY 2025

FY ended December 2025 · cache

₩6,580
Analyst consensus
·
Income statement
Revenue₩7B
Gross profit₩1.8B26% margin
EBITDA-₩19.5B-280% margin
Net income-₩21.8B-312.1% margin
Balance sheet & cash
Market cap₩447B
Total debt₩9.5B
Free Cash Flow-₩20.7B
Last declaration on 25 February 2026
Declarations51 total
  • Other
    Other(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Related company / holdingExecutives(filed)
    0DART
    449,447 sharesShareKRXDART:20241203000324
    Canonical exit: 3 Mar 2025 (T+90)
  • ▲
    Executives
    0DART
    679,389 sharesKRXDART:20241203000311
    Canonical exit: 2 Mar 2025 (T+90)
  • ▲
    부사장Executives(filed)
    0DART
    47,582 sharesShareKRXDART:20241203000356
    Canonical exit: 3 Mar 2025 (T+90)
  • ▲
    -Executives(filed)
    0DART
    18,346 sharesShareKRXDART:20241203000349
    Canonical exit: 3 Mar 2025 (T+90)
  • ▲
    최고과학책임자(CSO)Executives(filed)
    0DART
    164,014 sharesShareKRXDART:20241203000339
    Canonical exit: 3 Mar 2025 (T+90)
  • ▲
    Executives
    0DART
    4,774,130 sharesKRXDART:20241030000460
    Canonical exit: 23 Jan 2025 (T+90)
  • ▲
    -Executives(filed)
    0DART
    2,771,856 sharesShareKRXDART:20241030000472
    Canonical exit: 28 Jan 2025 (T+90)
  • ▼
    Related company / holdingExecutives
    0DART
    2,002,274 sharesKRXDART:20241030000381
  • ●
    -Executives
    0DART
    ShareKRXDART:20231109000479
  • ▼
    Related company / holdingExecutives
    0DART
    2,002,274 sharesKRXDART:20231109000493
  • ●
    -Executives
    0DART
    ShareKRXDART:20231109000473
  • ▼
    Related company / holdingExecutives
    0DART
    2,002,274 sharesKRXDART:20230814002204
  • ▼
    Related company / holdingExecutives
    0DART
    2,002,274 sharesKRXDART:20230510000742
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    0DART
    70,791 sharesShareKRXDART:20230220001369
  • ▼
    Related company / holdingExecutives(filed)
    0DART
    160,000 sharesKRXDART:20230220002092
  • ●
    Executives
    0DART
    313,632 sharesShareKRXDART:20230220001415
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Related company / holdingExecutives(filed)
    0DART
    319,783 sharesKRXDART:20230207000443
  • ●
    Executives
    0DART
    70,000 sharesShareKRXDART:20230207000427
  • ●
    Executives
    0DART
    1,116 sharesShareKRXDART:20230207000420
  • ▼
    Related company / holdingExecutives(filed)
    0DART
    2,002,274 sharesKRXDART:20220812000946

25 of 51 declarations

About 에스티큐브

Estcube is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments and therapeutic solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations